Newswise — A premier educational event sponsored by the Johns Hopkins Kelly Gynecologic Oncology Service and the Division of Gynecologic Oncology at Sibley Memorial Hospital, this one-day conference gathers more than 25 experts to provide cancer survivors and their caregivers, family and friends an innovative daylong educational and supportive program that leaves them strengthened by their new knowledge, comforted by the connections they have made with fellow survivors and inspired to spread awareness in their local communities.
With more than 200 participants expected to attend, top experts will lead sessions focused on a broad range of topics including innovative clinical trials, the latest FDA-approved therapies, management of side effects, genetics of gynecologic cancers, nutrition and exercise, and the use of mistletoe in cancer care. Breakout sessions will focus on each of the gynecologic cancers — ovarian, fallopian tube, primary peritoneal, uterine, cervical, vulvar and vaginal — their treatment paradigms today and what the current research might lead to in the future, with time for audience questions. Breakout sessions will also provide the opportunity to explore yoga, meditation, art therapy and journaling. The event will conclude with a panel discussion by five gynecologic cancer survivors.
What: Full-day conference geared toward anyone with a gynecologic cancer and their caregivers, family and friends who want to learn more about innovative treatments for gynecologic cancers, management of cancer and treatment-related symptoms, healthy living, and approaches to managing the strains of a cancer diagnosis.
When: Sept. 14, 2019, 8 a.m.–4:30 p.m.
Where: Renaissance Baltimore Harborplace Hotel, 202 E Pratt St, Baltimore, MD 21202
Subject matter experts available for interview:
Amanda Fader, M.D., is director of the Johns Hopkins Kelly Gynecologic Oncology Service and the Center for Rare Gynecologic Cancers at Johns Hopkins Medicine. An internationally recognized expert in the management of gynecologic cancers, Fader will lead the breakout session on rare gynecologic cancers and present in the main session on new frontiers in cancer screenings.
Stephanie Wethington, M.D., is director of the Susan L. Burgert, M.D., Gynecologic Oncology Survivorship Program, one of the only cancer survivorship programs developed solely for gynecologic cancer survivors. In this capacity, she organizes the survivorship conference, Kelly Gynecologic Oncology Service gynecologic cancer awareness month programming, and the ongoing support programs offered for survivors and their caregivers.
Stephanie Gaillard, M.D., is director of gynecologic cancer trials and an assistant professor of oncology at the Johns Hopkins University School of Medicine. Dr. Gaillard specializes in the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted and immune therapies into standard treatment regimens.
She will present on clinical trials in gynecologic cancers as well as lead the breakout session on ovarian malignancy.
Cornelia Trimble, M.D., professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine, specializes in HPV, cervical dysplasia and cutting edge treatments for HPV disease. Dr. Trimble is an international expert well recognized in the academic community and has translated this expertise into popular forums such as TED Talks.
At the conference, Dr. Trimble will discuss the role of vaccines in preventing and treating gynecologic cancers.